• Molecular NameDesonide
  • SynonymNA
  • Weight416.514
  • Drugbank_IDDB01260
  • ACS_NO638-94-8
  • Show 3D model
  • LogP (experiment)2.8
  • LogP (predicted, AB/LogP v2.0)2.81
  • pkaN/A
  • LogD (pH=7, predicted)2.81
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-3.93
  • LogSw (predicted, AB/LogsW2.0)0.04
  • Sw (mg/ml) (predicted, ACD/Labs)0.05
  • No.of HBond Donors2
  • No.of HBond Acceptors6
  • No.of Rotatable Bonds2
  • TPSA93.06
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA low potency topical corticosteroid that has been available since the 1970s. It is primarily used to treat atopic dermatitis (eczema), seborrheic dermatitis, psoriasis and contact dermatitis in both adults and children and has a fairly good safety profile[1] and is available as a cream, ointment, lotion, and, since September 19, 2006, as a foam under the tradename Verdeso Foam.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A